Prasol Chemicals IPO Shock: Stock Lists 10% Below Issue Price, What Should Investors Do Now?
Join Us
Follow Us
Prasol Chemicals shares made a weak market debut, listing nearly 10 per cent below its IPO price of Rs 676. The lower listing has reduced valuation concerns, but investors are now watching whether earnings growth can justify the company’s premium valuation.
✨ Key Takeaways
Shares of Prasol Chemicals started trading on Wednesday,16th Sep 2026 at Rs 610 per share on the NSE, marking a discount of 9.76 per cent against the issue price of Rs 676. The weak debut came despite decent investor interest during the initial public offering. The Rs 500 crore IPO, which opened between September 8 and September 10, received overall subscription of 3.30 times.
Looking for Quality Mid-Cap Growth Opportunities?
Explore DSIJ’s Mid Bridge - a research-driven service focused on fundamentally strong mid-cap companies with robust business models and long-term growth potential.
Download Service BrochureA discounted listing generally indicates that investors were not willing to assign the same valuation in the secondary market that was offered during the IPO. However, the lower listing price has also reduced the valuation multiple compared with the issue price.
Valuation Becomes Slightly More Comfortable
At the IPO price of Rs 676, Prasol Chemicals was valued at a price to earnings (P/E) multiple of 48.13 times. After listing at Rs 610, the valuation has reduced to around 43.43 times earnings. While the correction has lowered the premium investors are paying, the stock is still trading at a relatively high earnings multiple. The valuation argument will now depend on whether the company can continue improving its earnings and maintain its growth momentum.
Compared with listed specialty chemical peers, Prasol’s valuation appears lower than the average peer P/E of around 61.74 times. However, comparisons need to be viewed carefully as companies differ in terms of scale, margins, product portfolio and business profile.
Business Performance Remains The Key Monitorable
Prasol Chemicals operates in the specialty chemicals segment and manufactures a range of products used across industries. The company’s recent financial performance has shown improvement, but investors will need to track whether growth translates into sustainable profitability. Margins, raw material costs and capacity utilisation will remain important factors influencing future earnings.
The company reported an adjusted return on average equity (RoAE) of 20.37 per cent and return on capital employed (RoCE) of 22.43 per cent in FY26. However, its EBITDA margin stood at 11.30 per cent, which remains an important factor to monitor going ahead.
AlsoRead - Paytm Shares Surge 7% After UPI Rule Change: Big Money Opportunity Ahead?
What Investors Should Watch After Listing
The focus now shifts from the IPO response to the company’s operational performance.
Investors will closely track quarterly revenue growth, profitability trends and margin stability. Any improvement in operating performance could provide support to the valuation, while weaker earnings could put pressure on the stock.
Raw material costs will also remain important as specialty chemical companies are sensitive to input price movements. Changes in demand conditions, supply chains and industry trends could influence margins. The stock’s performance after listing will also depend on how investors assess its growth prospects compared with other specialty chemical companies.
Disclaimer: This article is for informational purposes only and should not be construed as investment advice.